22nd Century ROE 2011-2024 | XXII

Current and historical return on equity (ROE) values for 22nd Century (XXII) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
22nd Century ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.06B $0.00B 1244.44%
2024-06-30 $-0.12B $-0.00B 6971.43%
2024-03-31 $-0.14B $-0.01B -841.79%
2023-12-31 $-0.15B $-0.01B -375.00%
2023-09-30 $-0.14B $0.01B -209.09%
2023-06-30 $-0.08B $0.07B -84.10%
2023-03-31 $-0.07B $0.08B -68.51%
2022-12-31 $-0.06B $0.10B -63.10%
2022-09-30 $-0.05B $0.12B -54.65%
2022-06-30 $-0.04B $0.10B -56.95%
2022-03-31 $-0.04B $0.06B -49.66%
2021-12-31 $-0.03B $0.07B -45.07%
2021-09-30 $-0.02B $0.08B -36.64%
2021-06-30 $-0.02B $0.09B -32.62%
2021-03-31 $-0.02B $0.05B -40.00%
2020-12-31 $-0.02B $0.04B -36.89%
2020-09-30 $-0.02B $0.05B -33.93%
2020-06-30 $-0.03B $0.05B -43.67%
2020-03-31 $-0.03B $0.06B -47.26%
2019-12-31 $-0.03B $0.06B -41.77%
2019-09-30 $-0.03B $0.06B -44.96%
2019-06-30 $-0.01B $0.06B -18.44%
2019-03-31 $-0.01B $0.07B -16.38%
2018-12-31 $-0.01B $0.07B -11.96%
2018-09-30 $-0.00B $0.08B -5.25%
2018-06-30 $-0.01B $0.07B -20.47%
2018-03-31 $-0.01B $0.08B -17.48%
2017-12-31 $-0.01B $0.08B -34.67%
2017-09-30 $-0.01B $0.03B -48.48%
2017-06-30 $-0.01B $0.03B -55.17%
2017-03-31 $-0.01B $0.02B -63.16%
2016-12-31 $-0.01B $0.02B -67.61%
2016-09-30 $-0.01B $0.02B -81.36%
2016-06-30 $-0.01B $0.01B -84.21%
2016-03-31 $-0.01B $0.02B -66.67%
2015-12-31 $-0.01B $0.01B -80.00%
2015-09-30 $-0.01B $0.01B -96.55%
2015-06-30 $-0.01B $0.02B -87.50%
2015-03-31 $-0.02B $0.01B -107.14%
2014-12-31 $-0.02B $0.02B -118.52%
2014-09-30 $-0.02B $0.02B -153.19%
2014-06-30 $-0.03B $0.01B -1200.00%
2014-03-31 $-0.03B $0.01B 1866.67%
2013-12-31 $-0.03B $0.01B 433.33%
2013-09-30 $-0.02B $-0.02B 231.58%
2013-06-30 $-0.01B $-0.01B 121.74%
2013-03-31 $-0.01B $-0.01B 155.56%
2012-12-31 $-0.01B $-0.01B 184.62%
2012-09-30 $-0.00B $-0.00B 50.00%
2012-06-30 $-0.00B $-0.00B 44.44%
2012-03-31 $-0.00B $-0.00B 80.00%
2011-12-31 $-0.00B $-0.00B 44.44%
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.004B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $202.113B 20.44
Altria (MO) United States $96.147B 11.30
British American Tobacco (BTI) United Kingdom $77.732B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $26.763B 0.00
Universal (UVV) United States $1.410B 11.04
Turning Point Brands (TPB) United States $1.109B 21.31